These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 39329730)
1. Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer. Maietta I; Viscusi E; Laudati S; Iannaci G; D'Antonio A; Melillo RM; Motti ML; De Falco V Cells; 2024 Sep; 13(18):. PubMed ID: 39329730 [TBL] [Abstract][Full Text] [Related]
2. p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors. Maietta I; Del Peschio F; Buonocore P; Viscusi E; Laudati S; Iannaci G; Minopoli M; Motti ML; De Falco V Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612117 [TBL] [Abstract][Full Text] [Related]
3. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937 [TBL] [Abstract][Full Text] [Related]
4. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells. Park SH; Seong MA; Lee HY Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415 [TBL] [Abstract][Full Text] [Related]
6. Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer. Shangary S; Ding K; Qiu S; Nikolovska-Coleska Z; Bauer JA; Liu M; Wang G; Lu Y; McEachern D; Bernard D; Bradford CR; Carey TE; Wang S Mol Cancer Ther; 2008 Jun; 7(6):1533-42. PubMed ID: 18566224 [TBL] [Abstract][Full Text] [Related]
7. Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cells. Jackson MW; Patt LE; LaRusch GA; Donner DB; Stark GR; Mayo LD J Biol Chem; 2006 Jun; 281(24):16814-20. PubMed ID: 16621805 [TBL] [Abstract][Full Text] [Related]
8. AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex. de Polo A; Luo Z; Gerarduzzi C; Chen X; Little JB; Yuan ZM J Mol Cell Biol; 2017 Apr; 9(2):154-165. PubMed ID: 27927748 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models. Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271 [TBL] [Abstract][Full Text] [Related]
10. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201 [TBL] [Abstract][Full Text] [Related]
11. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma. Liu Q; Mier JW; Panka DJ Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745 [TBL] [Abstract][Full Text] [Related]
12. E2F1-dependent oncogenic addiction of melanoma cells to MDM2. Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494 [TBL] [Abstract][Full Text] [Related]
13. Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence. Luo H; Yount C; Lang H; Yang A; Riemer EC; Lyons K; Vanek KN; Silvestri GA; Schulte BA; Wang GY Lung Cancer; 2013 Aug; 81(2):167-73. PubMed ID: 23683497 [TBL] [Abstract][Full Text] [Related]
14. Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway. Koster R; Timmer-Bosscha H; Bischoff R; Gietema JA; de Jong S Cell Death Dis; 2011 Apr; 2(4):e148. PubMed ID: 21509038 [TBL] [Abstract][Full Text] [Related]
15. The Vascular Endothelial Growth Factor-A phosphorylates Murine Double Minute-2 on its Serine 166 via the Extracellular Signal-Regulated Kinase 1/2 and p90 Ribosomal S6 Kinase in primary human endothelial cells. Aiken J; Birot O Biochem Biophys Res Commun; 2016 Sep; 478(4):1548-54. PubMed ID: 27591897 [TBL] [Abstract][Full Text] [Related]
16. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer. Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation. Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736 [TBL] [Abstract][Full Text] [Related]
18. A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis and sensitizes lung cancer cells to chemotherapy. Sun SH; Zheng M; Ding K; Wang S; Sun Y Cancer Biol Ther; 2008 Jun; 7(6):845-52. PubMed ID: 18340116 [TBL] [Abstract][Full Text] [Related]
19. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine. Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860 [TBL] [Abstract][Full Text] [Related]
20. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy. Azmi AS; Philip PA; Aboukameel A; Wang Z; Banerjee S; Zafar SF; Goustin AS; Almhanna K; Yang D; Sarkar FH; Mohammad RM Curr Cancer Drug Targets; 2010 May; 10(3):319-31. PubMed ID: 20370686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]